Jo Palmer-Phillips
About Jo Palmer-Phillips
Jo Palmer-Phillips, Chief Development Officer
Jo Palmer-Phillips is the Chief Development Officer with over 18 years of experience in the pharmaceutical industry. In her current role, she brings her extensive expertise in clinical development, particularly specializing in pain and migraine. As an executive, she oversees the strategic growth and operational efficacy of clinical development projects, ensuring they meet the highest standards.
Jo Palmer-Phillips: Neuropsychologist
Jo Palmer-Phillips is also a neuropsychologist, bringing a unique blend of psychological and pharmaceutical expertise to her roles. This background enables her to approach clinical development with a comprehensive understanding of neurological disorders and their treatment, particularly focusing on conditions such as pain and migraine.
Jo Palmer-Phillips' Experience in Clinical Development
With over 18 years of experience, Jo Palmer-Phillips has worked in various capacities within the realm of clinical development. She has held significant positions in both clinical operations and clinical strategy. Her career includes leadership roles at major pharmaceutical firms such as Roche, GSK, Convergence Pharmaceuticals, and Biogen, where she has successfully led multidisciplinary clinical teams.
Leadership at Convergence Pharmaceuticals
As a founding member of Convergence Pharmaceuticals Ltd, Jo Palmer-Phillips was integral to the company's leadership team. In her role as Head of Clinical Operations, she was responsible for designing and managing the full-service outsourcing of phase 1 and 2 clinical studies focused on pain. Additionally, she played a crucial role in establishing and maintaining the Quality System at Convergence, ensuring compliance and high standards throughout clinical practices.